Contents
Contents
In the Matrix Medical Network Medicare Advantage settlement, the company agreed to pay $36.5 million to resolve allegations that its home assessments generated unsupported diagnoses that raised insurers’ payments. Matrix also admitted reporting conditions that its assessment forms lacked sufficient clinical information to support. This Medicare Advantage fraud case reaches the vendor producing the diagnosis, the coding work after the visit, and the business of selling insurers higher risk scores.
The Justice Department announced the resolution on June 3, 2026. Matrix, formally Community Care Health Network LLC, is a Nashville healthcare company that contracts with Medicare Advantage insurers to assess members in their homes. The national announcement put its settlement inside a $56.5 million headline that also covered HealthFair and HealthFair’s former owner. Those were separate cases, with different assessment programs and different conduct.
Matrix sold insurers assessments that could identify additional diagnoses and increase their Medicare payments. In its account of Matrix’s admitted conduct, the U.S. Attorney’s Office for the Southern District of New York reported that Matrix contracted with more than 30 Medicare Advantage organizations. Some contracts required it to help capture diagnoses for risk adjustment and report the insurer’s return on investment.
That return had a specific meaning. Matrix admitted calculating it partly from the estimated increase in Medicare reimbursements attributable to risk-score increases from its assessments. The government alleged that Matrix marketed its ability to find conditions that patients’ primary-care physicians had not reported and advertised the resulting increase in HCC scores.
The payment path from diagnosis to risk score explains the sale. An additional qualifying diagnosis can therefore be valuable to the insurer long after the assessment ends.
According to the government’s allegations, insurers generally paid Matrix $350 to $450 per assessment. The assessment fee bought a visit whose diagnoses could affect the insurer’s government payments. The government also said Matrix had to certify the accuracy and truthfulness of the data it generated for insurers’ payment claims.
The Matrix allegations covered home assessments from 2014 through 2019 and seven chronic conditions. Matrix admitted that, in numerous instances, its assessment forms did not contain sufficient clinical information to support reporting these conditions:
The government’s account of the diagnoses went beyond thin forms. It alleged that Matrix regularly recorded complex conditions without the testing, imaging or other clinical steps necessary to establish them, and that the diagnoses failed the applicable coding and documentation requirements.
Matrix admitted that nurse practitioners typically performed the assessments, collected health histories and medication information, conducted physical exams, and recorded diagnostic information electronically. They did not provide clinical treatment or prescribe medications. The government further alleged that Matrix gave generalized suggestions to follow up with doctors rather than referring patients to specialists. The government alleged that taxpayers paid more for diagnoses that neither affected care, treatment or management during the visit nor had adequate support in the assessment documentation.
The government compared Matrix’s diagnoses with those reported by other providers in the year of the home visit, the two preceding years and the two following years. It alleged that other providers treating the patient frequently had not diagnosed those conditions during that period. Matrix also admitted that its assessments produced diagnoses and resulting risk-adjustment submissions that frequently had not been reported by another provider treating the member during that window. The government’s account joined the absence elsewhere to insufficient support at the visit and failures to follow coding requirements.
For an insider, that makes the original assessment more useful than a bare count of newly found conditions. The form shows what the clinician recorded. The other providers’ records show the patient’s wider care. The diagnosis sent to the insurer shows what entered the payment process. We examine how those accounts fit together, including what happened to a condition found only at the home visit.
The government described an electronic check-the-box form recording the patient’s reported medical history and a basic physical assessment. It alleged that Matrix’s coding teams reviewed those forms and selected diagnosis codes for insurers to submit to the Centers for Medicare and Medicaid Services. Its quality-improvement staff then reviewed the nurse practitioners’ entries for additional diagnoses and urged the practitioners to add them. The New York announcement puts it plainly:
At times, MATRIX even added diagnoses without the nurse practitioner’s signoff.
Government allegation summarized in the U.S. Attorney’s Office for the Southern District of New York’s Matrix settlement announcement, June 3, 2026
That places an important decision after the clinician has left the home. A practitioner may know what the examination supported, while a coder or reviewer sees what the company subsequently wanted added. A health-plan employee may see only the diagnosis delivered by the vendor.
The government alleged that Matrix focused on diagnoses that would raise its customers’ payments rather than ensuring that all diagnoses were supported. The question for those inside the workflow is what happened between the completed assessment and the final code. The visit, the review request and the submitted diagnosis can tell different parts of that story.
Matrix admitted and accepted responsibility for specific conduct, including reporting the seven conditions without enough clinical information on its forms and calculating customer returns from increased Medicare reimbursements. It also admitted that insurers frequently submitted the resulting codes to Medicare and often received higher payments. Those admissions connect the assessment documentation to the money. Matrix also agreed to five years of outside oversight of its risk-adjustment work under a Corporate Integrity Agreement with the Department of Health and Human Services Office of Inspector General.
HealthFair’s settlement concerned assessments on mobile health care buses from 2015 through 2017. Matrix acquired HealthFair in 2018 and shut down its operations by 2020. The government described distinct HealthFair allegations, including diagnoses that contradicted test results.
The government alleged that providers reported conditions including HIV/AIDS and metastatic cancer without documentation establishing or confirming them. Other diagnoses, including morbid obesity, drug dependence and major depressive disorder, allegedly rested solely on patient attestation, claims history, past medical history or medication.
The government also alleged congestive heart failure and heart arrhythmia diagnoses despite contradictory electrocardiogram and echocardiogram results, and thrombophilia diagnoses based solely on separate atrial fibrillation diagnoses. According to the government, HealthFair sent the diagnoses to insurer customers, which often submitted them for risk-adjusted payment.
HealthFair agreed to pay $5 million, and its former owner agreed to pay $15 million, to resolve the Texas whistleblower case. Matrix’s home-assessment settlement resolved the New York case. The acquisition connects the businesses, but the HealthFair conduct described here preceded it.
A former Matrix employee brought the Matrix qui tam case, and the government joined it. HealthFair’s chief medical officer brought the separate HealthFair case. The announced whistleblower rewards were $7.3 million for the former Matrix employee and $3.6 million for HealthFair’s former chief medical officer.
A whistleblower case under the False Claims Act can pay the whistleblower 15% to 30% of what the government recovers. The insurers got the money, but the people who brought these cases knew the work that produced the diagnoses.
Diagnosis coding can change what Medicare pays without a corresponding change in the patient’s health. The 2015 working paper Upcoding or Selection? Evidence From Medicare on Squishy Risk Adjustment, hosted by Duke University, estimated that private Medicare plan enrollment generated diagnosis-based risk scores 6% to 16% higher than the same enrollees would generate in fee-for-service Medicare. Its discussion of home assessments identifies the commercial attraction:
The visit is necessary in order to add the relevant, reimbursable diagnoses for the current plan year and relatively low cost.
The Office of Inspector General later measured the scale of the assessment channel. Its October 2024 report on health risk assessments estimated $7.5 billion in Medicare Advantage payments for 2023 from diagnoses appearing only on assessments or assessment-linked chart reviews, with no other service record in 2022. In-home assessments and their linked reviews generated almost two-thirds of that amount. OIG raised concerns about both inaccurate diagnoses and patients missing needed care.
Cigna provides a closer enforcement parallel. Its $37 million home-visit settlement in 2023 included admissions concerning diagnoses unsupported by vendor forms and unreported by other providers during the visit year. The shared issue is the clinical support for an assessment diagnosis that reaches Medicare’s payment calculation. Matrix’s case puts the assessment vendor’s own decisions at the center.
If you saw diagnoses pushed beyond what an assessment supported, tell our whistleblower experts where the record and the code parted company. We build the case around your knowledge of the assessment business, bring in Medicare Advantage whistleblower lawyers who understand vendor coding and risk-adjusted payments, and stand beside you through the pursuit of a recovery.